The University of Kansas Announces Grant Funding for Knee Imaging Biomarkers Acquired from Weight Bearing CT

The University of Kansas Medical Center Research Institute Department of Rehabilitation Medicine has received a grant from the National Institute of Arthritis Musculoskeletal and Skin Diseases (NIAMS), one of the 27 Institutes and Centers at the National Institutes of Health (NIH), to fund three years of research on the usefulness of bilateral weight bearing CT imaging and the critical need for more sensitive and affordable imaging biomarkers.

Osteoarthritis (OA) is the most prevalent form of arthritis, and the knee is the most commonly affected weight-bearing joint. The high cost of clinical trials creates a barrier for effective treatment development. Therefore, introduction of more specific and sensitive biomarkers could help to advance therapeutic development by reducing the time and sample sizes required for clinical trials.

Proposed Outcomes

There is an urgent need for imaging biomarkers that allow for identification of the best time in which patients will respond to treatment, and a means to analyze the efficiency of interventions. Early studies demonstrated the diagnostic value of bilateral weight-bearing CT in identifying knee OA symptoms accurately, as well as the feasibility to detect meniscal tears not detected by non-weight bearing MRI.

The grant from NIAMS will fund a study to validate the proposed imaging biomarkers and begin the qualification process for more responsive OA imaging biomarkers acquired using low-dose, bilateral standing CT imaging. Substantial advantages are offered over traditional radiographic biomarkers, including increased responsiveness to temporal changes in the joints, and a better reflection of the symptoms and severity of the disease. Additionally, this research will determine the prognostic validity of standing CT findings for detecting progression and worsening pain in people who currently suffer from or are at risk for knee OA.

Long-Term Impact

With the support of NIAMS, this research holds promise to detect joint damage earlier, and accelerate the pace of scientific discovery and clinical trials. The continuing impact will be evident through a shift in knee joint imaging with an improved biomarkers for monitoring knee OA disease features. If the additional meniscal extrusions detected on bilateral standing CT are clinically relevant, then standing CT could improve identification of the most appropriate patients for clinical trials – those at risk of rapid OA progression. Successful completion will provide improved biomarkers that will help those who suffer from knee OA through making clinical trials more affordable and accelerating therapeutic improvement.

For more information on visualizing cartilage and menisci in the knee using standing CT arthrogram versus MRI, click here.

Read more at curvebeam.com

Follow us on social media for the latest updates in B2B!

Latest

Finishing Industry Trends and Challenges: Manufacturing A Stronger Standard
July 2, 2022
This episode of Manufacturing A Stronger Standard is live from FABTECH 2021. Host and President of LestaUSA and DeGeest Corp. Derek DeGeest, talked with Scott Francis, editor-in-chief of Products Finishing, the Read more
Manufacturing a Stronger Standard: Richard Wilcox and LestaUSA Increasing Customers’ Production with New Automation Systems
July 2, 2022
Achieving automation on the finishing side requires many pieces—two of the most important being the conveyor system and robotics. Host of Manufacturing a Stronger Standard Derek DeGeest spoke with Systems Sales Read more
Manufacturing a Stronger Standard: Nordson Customer Success with LestaUSA Technology
July 2, 2022
Derek DeGeest was back at FABTECH 2021 for another Manufacturing a Stronger Standard conversation. He spoke with Frank Mohar, Regional Sales Manager at Nordson, about the partnership between the companies and Read more